Mississippi Administrative Code
Title 30 - Professions and Occupations
Part 2640 - Rules Pertaining to Prescribing, Administering, and Dispensing Medication
Chapter 2 - Cannabis Certification
Rule 30-2640-2.8 - Mississippi Prescription Monitoring Program (MPMP) and Urine Drug Screening

Certifying Practitioners who certify patients for cannabis must review the MPMP at each patient encounter involving certification, re-certification, or follow-up related to medical cannabis. MPMP data reviewed shall include all information since the previous review. The certifying practitioner shall note in the patient's chart that the MPMP was reviewed and provide appropriate information regarding the findings of said review.

As part of the in-person evaluation of a patient for initial certification or for re-certification each year, certifying practitioners shall conduct urine drug screening (UDS) and other laboratory tests necessary for full evaluation of the patient's eligibility for medical cannabis. In the absence of urine, other testing methods may be used. Tests must include, at a minimum, assays for opioids, benzodiazepines, amphetamines, cocaine, and cannabis. Inconsistent UDS should be utilized as a tool to determine compliance with treatment.

Miss. Code Ann. § 73-43-11 (1972, as amended).